PFO Clinical Trials

11 recruitingLast updated: May 13, 2026

There are 11 actively recruiting pfo clinical trials across 14 countries. Studies span Not Applicable. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Norfolk, Virginia, United States. Updated daily from ClinicalTrials.gov.


PFO Trials at a Glance

11 actively recruiting trials for pfo are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in New York, Boston, and Norfolk. Lead sponsors running pfo studies include Coherex Medical Inc., Chinese Academy of Medical Sciences, Fuwai Hospital, and China National Center for Cardiovascular Diseases.

Browse pfo trials by phase

Treatments under study

About PFO Clinical Trials

Looking for clinical trials for PFO? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new PFO trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about PFO clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

StrokePFO - Patent Foramen Ovale
W.L.Gore & Associates636 enrolled45 locationsNCT03821129
Recruiting

Abbott Structural Heart Device Registry

Heart DiseasesValvular Heart DiseasePFO - Patent Foramen Ovale+3 more
Abbott Medical Devices2,500 enrolled28 locationsNCT06590467
Recruiting

Pulmonary Embolism and Right-to-Left Shunts

Pulmonary Embolism (PE)StrokePulmonary Arteriovenous Malformation+3 more
Tufts Medical Center256 enrolled1 locationNCT07519876
Recruiting

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

ElderlyIschemic StrokeEmbolic Stroke of Undetermined Source+1 more
Taichung Veterans General Hospital400 enrolled3 locationsNCT07479147
Recruiting
Not Applicable

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

Cryptogenic StrokePFO - Patent Foramen OvalePFO+2 more
Recross Cardio, Inc.15 enrolled5 locationsNCT07172464
Recruiting

Non-Invasive Detection of Right-to-Left Cardiac Shunts

Patent Foramen Ovale (PFO)
Scripps Health75 enrolled1 locationNCT07420400
Recruiting
Not Applicable

Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device

Hereditary Haemorrhagic TelangiectasiaPulmonary Arteriovenous MalformationPFO - Patent Foramen Ovale
St. Antonius Hospital40 enrolled1 locationNCT07414446
Recruiting
Not Applicable

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine

migraine headacheMigrainePFO - Patent Foramen Ovale+1 more
Chinese Academy of Medical Sciences, Fuwai Hospital400 enrolled2 locationsNCT06203873
Recruiting

Cerebral Microembolization Associated With PFO Closure

Atrial Septal DefectPatent Foramen Ovale (PFO)Thrombosis Cardiac
China National Center for Cardiovascular Diseases800 enrolled1 locationNCT06347276
Recruiting

Coherex-PFO-Sleep Hypoxia: A multi-center study to determine the response to closure of patent foramen ovale (PFO) with the Coherex FlatStentTM EF PFO Closure System (EF is part of the trade mark name and stands for Enhanced Foam) in patients diagnosed with PFO and significant oxygen desaturation in obstructive sleep apnea (OSA)

Significant oxygen desaturation associated with right-to-left shunts through a PFO in Obstructive Sleep Apnea(OSA) patients
Coherex Medical Inc.50 enrolled3 locationsACTRN12610000184077
Recruiting

COHEREX-EU:A Multi-Center Study to Evaluate the Safety and Efficacy of the Coherex FlatStent Patent Foramen Ovale(PFO) Closure System

Symptomatic Patent Foramen OvaleThe Coheres FlatStent Patemnt Foramen Oveale (PFO) Closure System will be implanted when closure of a Patent Foramen Ovale is clinically indicated. Each patient who receives an implant will be followed for six months after the the FlatStent is implanted. Enrollment will continue for six months or until 50 patients have been enrolled.
Coherex Medical Inc.50 enrolled2 locationsACTRN12607000623493